Cargando…

Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma

Tumor-associated autoantibodies are promising diagnostic biomarkers for early detection of tumors. We have screened a novel tumor-associated autoantibody in hepatocellular carcinoma (HCC) model mice. Its target antigen was identified as eukaryotic translation initiation factor 3 subunit A (EIF3A) by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heo, Chang-Kyu, Hwang, Hai-Min, Lee, Hye-Jung, Kwak, Sang-Seob, Yoo, Jong-Shin, Yu, Dae-Yeul, Lim, Kook-Jin, Lee, Soojin, Cho, Eun-Wie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667438/ https://www.ncbi.nlm.nih.gov/pubmed/31363116 http://dx.doi.org/10.1038/s41598-019-47365-4

Ejemplares similares

Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma
por: Hwang, Hai-Min, et al.
Publicado: (2018)

Cyclic Peptide Mimotopes for the Detection of Serum Anti–ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2020)

Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide-conjugated BSA
por: Heo, Chang-Kyu, et al.
Publicado: (2022)

Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012)

Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer
por: HEO, CHANG-KYU, et al.
Publicado: (2012)

eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma
por: Steinmann, Sara M., et al.
Publicado: (2023)

Pediatric hepatocellular carcinoma associated with Niemann–Pick disease type C: Case report and literature review
por: Hwang, Soojin, et al.
Publicado: (2022)

Genome Editing of eIF4E1 in Tomato Confers Resistance to Pepper Mottle Virus
por: Yoon, Yoo-Joung, et al.
Publicado: (2020)

Autoantibody Biomarkers in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2020)

eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma
por: Fang, Chao, et al.
Publicado: (2021)

Dendritic eIF4E-binding Protein 1 (eIF4E-BP1) mRNA Is Upregulated by Neuronal Activation
por: Moon, Il Soo, et al.
Publicado: (2012)

EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma
por: Lee, Hsin-Yi, et al.
Publicado: (2018)

Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma
por: Goh, Tae Sik, et al.
Publicado: (2019)

Toxicity of red Liriope platyphylla manufactured by steaming process on liver and kidney organs of ICR mice
por: Choi, Sun-Il, et al.
Publicado: (2012)

An interaction between eIF4A3 and eIF3g drives the internal initiation of translation
por: Chang, Jeeyoon, et al.
Publicado: (2023)

Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma
por: Middleton, Catrin H., et al.
Publicado: (2014)

Autoantibody signature in hepatocellular carcinoma using seromics
por: Zhang, Shu, et al.
Publicado: (2020)

Expression of Organic Anion Transporting Polypeptides in an H-Ras 12V Transgenic Mouse Model of Spontaneous Hepatocellular Carcinoma
por: Kim, Honsou, et al.
Publicado: (2021)

Synergistic activation of eIF4A by eIF4B and eIF4G
por: Nielsen, Klaus H., et al.
Publicado: (2011)

eIF2A, an initiator tRNA carrier refractory to eIF2α kinases, functions synergistically with eIF5B
por: Kim, Eunah, et al.
Publicado: (2018)

Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
por: Lee, Soon Kyu, et al.
Publicado: (2021)

Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies
por: Ceribelli, Angela, et al.
Publicado: (2020)

The Autophagy-Related Marker LC3 Can Predict Prognosis in Human Hepatocellular Carcinoma
por: Lee, Yoo Jin, et al.
Publicado: (2013)

Targeting therapy-resistant lung cancer stem cells via disruption of the AKT/TSPYL5/PTEN positive-feedback loop
por: Kim, In-Gyu, et al.
Publicado: (2021)

PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells
por: Lee, Sol, et al.
Publicado: (2022)

Correction: The Autophagy-Related Marker LC3 Can Predict Prognosis in Human Hepatocellular Carcinoma
por: Lee, Yoo Jin, et al.
Publicado: (2013)

A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma
por: Yoo, So Young, et al.
Publicado: (2019)

Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study
por: Yoon, Jun Sik, et al.
Publicado: (2019)

An eIF for proliferation
por: LeBrasseur, Nicole
Publicado: (2008)

The Initiation Factors eIF2, eIF2A, eIF2D, eIF4A, and eIF4G Are Not Involved in Translation Driven by Hepatitis C Virus IRES in Human Cells
por: González-Almela, Esther, et al.
Publicado: (2018)

Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma
por: Shek, Felix H., et al.
Publicado: (2012)

Translation of Sindbis Subgenomic mRNA is Independent of eIF2, eIF2A and eIF2D
por: Sanz, Miguel Angel, et al.
Publicado: (2017)

eIF4B, eIF4G and RNA regulate eIF4A activity in translation initiation by modulating the eIF4A conformational cycle
por: Harms, Ulf, et al.
Publicado: (2014)

Prevalence and Clinical Implications of Incidental Aortic Arch Abnormalities on Contrast-Enhanced Neck MR Angiography: A Single-Center Experience
por: Hwang, Minhee, et al.
Publicado: (2023)

Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
por: Kim, Ji-Hye, et al.
Publicado: (2016)

Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis
por: Fang, Qinghua, et al.
Publicado: (2019)

Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
por: Marzęcka, Milena, et al.
Publicado: (2022)

Ultrasonographic features of pure ductal carcinoma in situ of the breast: correlations with pathologic features and biological markers
por: Cha, Hwajin, et al.
Publicado: (2018)

Inhibition of eIF6 Activity Reduces Hepatocellular Carcinoma Growth: An In Vivo and In Vitro Study
por: Scagliola, Alessandra, et al.
Publicado: (2022)

Thyroid Autoantibody Positive Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Jung, Yoori, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0dhjk8h3aes4et2hln25d71ldn